Seminal work has challenged the idea that differentiated cells cannot change their identity and has underscored the powerful role played by transcription factors in instructing lineage reprogramming [4] [5] [6] . However, whether all cells possess the same ability to change identity is still unclear. In the CNS, neurons represent a quintessential example of a permanently post-mitotic and differentiated cell type. Despite the tight control over maintenance of neuronal identity, it is not known whether neurons can be lineage reprogrammed to a new cell fate under appropriate stimuli.
Seminal work has challenged the idea that differentiated cells cannot change their identity and has underscored the powerful role played by transcription factors in instructing lineage reprogramming [4] [5] [6] . However, whether all cells possess the same ability to change identity is still unclear. In the CNS, neurons represent a quintessential example of a permanently post-mitotic and differentiated cell type. Despite the tight control over maintenance of neuronal identity, it is not known whether neurons can be lineage reprogrammed to a new cell fate under appropriate stimuli.
Previous work has demonstrated that an entire mouse can be cloned through the transfer of nuclei of at least some neuron types into enucleated oocytes 7, 8 . This work supports the argument that in the CNS neurons resist phenotypic changes without irreversible loss of genetic material and that epigenetic mechanisms that may be in place to maintain cell identity can be reset under appropriate conditions. In support of this notion is the demonstration that spinal motor neurons can undergo a class switch if manipulated immediately after exit from the cell cycle [9] [10] [11] . To determine whether excitatory neurons of the cerebral cortex, one of the most complex regions of the CNS, can undergo direct lineage reprogramming after they have become post-mitotic and whether this can occur in vivo, we have investigated whether a lineage conversion between layer-II/III callosal projection neurons and layer-V/VI corticofugal projection neurons 12 can be instructed within the brain. Both of these neuronal subtypes are generated during development and do not regenerate in the adult 13 . The molecular programs controlling corticofugal projection neuron (CFuPN) development are emerging 12, 14 . In particular, the transcription factor Fezf2 is a powerful master gene necessary for the development of subcerebral projection neurons, a class of CFuPNs (refs 15-17) , and whose overexpression is sufficient to confer corticofugal neuronal identity on neural progenitors fated to generate different neuronal populations 17, 18 . Here, we developed two different approaches to ectopically express Fezf2 in post-mitotic layer-II/III callosal projection neurons (CPNs). First, to determine whether at the earliest stages of post-mitotic development CPNs retain the ability to lineage reprogram, we have taken advantage of the Cdk5r gene promoter 19 to drive Fezf2 expression in young post-mitotic CPNs. In the developing cerebral cortex, Cdk5r is restricted to migratory, post-mitotic neurons 20, 21 . To confirm the specificity of its minimal promoter, we co-electroporated Cdk5r-DsRed and Nestin-eGFP expression vectors in embryonic day (E)13.5 cortical progenitors and determined their expression patterns. As expected, we found that eGFP was restricted to progenitors whereas DsRed was restricted to post-mitotic CPNs (Supplementary Fig. S1 ). control and Fezf2-electroporated embryos, GFP-positive neurons were visible in the upper layers; however, neurons that expressed Fezf2 showed a reproducible change in migration, with a subset of neurons located ectopically in the deep layers (Fig. 1c) . We thus concentrated our analysis only on GFP-positive neurons located within layer II/III. We first analysed the molecular identity of the neurons generated. We found that ER81, CRYM, TLE4, CTIP2, ZFPM2 and Clim1-all markers of CFuPNs excluded from layer-II/III CPNs (refs 12,14,16, 22 )-were present in layer II/III of the Cdk5r-Fezf2 eGFP cortex (n = 4) but not in control Cdk5r-Ctl eGFP -electroporated cortex (n = 4) at all ages examined (Figs 1-3 ). Next we quantified at the single-neuron level the percentage of GFP-positive neurons in layers II/III that expressed CFuPN and CPN proteins. We found that, at P7, CPNs that had received Fezf2 expressed ER81, a protein normally restricted to layer V (ref. 22 Fig. 1b) . These results show that young post-mitotic CPNs are able to acquire molecular features of CFuPNs.
To further assess the extent of these molecular changes, we investigated the combinatorial profile of expression of these subtypespecific proteins. We found that up to 75.6% of Fezf2-expressing CPNs that expressed one CFuPN protein also co-expressed a second CFuPN marker. Specifically, Fezf2-expressing CPNs co-expressed CRYM and ER81 (19.90 ± 6.67%), CRYM and TLE4 (32.91 ± 2.77%), CRYM and CTIP2 (11.59 ± 0.99%), CTIP2 and ER81 (13.19 ± 0.98%), and CTIP2 and TLE4 (15.47 ± 0.53%; Fig. 2a,b) . Notably, a distinct fraction of Fezf2-expressing CPNs that was negative for CUX1 (65.08±3.02%) was also positive for CRYM (33.58 ± 0.88%) and CTIP2 (13.34 ± 1.02%; Fig. 2b ), indicating that they had made a clear lineage choice. Fezf2-expressing CPNs were also calculated to co-express CRYM, CTIP2 and ER81 (8.23 ± 3.35%), CRYM, CTIP2 and TLE4 (9.37 ± 2.22%) and to be positive for CRYM and CTIP2 but negative for CUX1 (8.30 ± 3.28%; Fig. 2c ). These results demonstrate that, in an early period of post-mitotic life, CPNs of layer II/III are able to reprogram their molecular identity, acquiring combinatorial expression of CFuPN proteins and repressing CPN proteins.
Interestingly, reprogrammed CPNs also expressed the transcription factor gene Clim 1 (Fig. 1c) , which is not a direct target gene of Fezf2 (Lodato, S. et al., Harvard University, unpublished data), providing evidence that the reprogramming process goes beyond activation of a first line of Fezf2 direct target genes to induce a broader program of CFuPN gene expression.
It is possible that reprogrammed CPNs may not be stable and, over time, revert to their original identity or die. We therefore assessed the expression of ER81, CRYM and CUX1 in Fezf2-expressing CPNs over time. ER81 continued to be expressed in Fezf2-expressing CPNs at P14 (20.21 ± 2.10% versus 0% in Cdk5r-Ctl eGFP ) and P28 (17.96 ± 1.78% versus 0% in Cdk5r-Ctl eGFP ; Fig. 3a,b) . Similarly, CRYM was maintained at P14 (16.99 ± 3.74% versus 0% in Cdk5r-Ctl eGFP ) and P28 (17.74 ± 0.83% versus 0.29 ± 0.29% in Cdk5r-Ctl eGFP ; Fig. 3a,b) . Finally, we found that the percentage of CUX1-positive neurons remained low in the Cdk5r-Fezf2 eGFP -targeted CPN population over time (Fig. 3a,b) . Together, these data show that Cdk5r-Fezf2 eGFPelectroporated, reprogrammed CPNs retained CFuPN molecular identity more than four weeks after the initial expression of Fezf2. Importantly, there is a reduction in the fraction of Fezf2-expressing CPNs that express ER81 and CRYM between P7 and P14; however, these values stabilize after P14.
To investigate whether this decrease was due to cell death, we quantified the number of caspase-3-positive cells among GFPexpressing neurons, in both Cdk5r-Fezf2 eGFP and Cdk5r-Ctl eGFP cortices at P7, P14 and P28. We found minimal cell death and no significant differences between groups ( Supplementary Fig. S2a,b) . We conclude that the reduction in the percentages of ER81-and CRYM-positive Cdk5r-Fezf2 eGFP -expressing CPNs observed by P14 is not due to cell death but rather to the inability to maintain expression of these markers. In agreement, the percentage of CUX1-negative Cdk5r-Fezf2 eGFP -expressing CPNs remained unchanged over time. Together, the data indicate that upper-layer-II/III CPNs can undergo an early post-mitotic change of identity in response to cell-autonomous signals instructive of a different neuronal lineage. Furthermore, a significant proportion of reprogrammed neurons maintain their new molecular identity in postnatal cortex.
Given that genes important for neuronal subtype-specific differentiation in the cortex are still expressed at these early stages of development 24 , we next investigated whether CPNs can reprogram their molecular identity at later post-mitotic ages, when they are already positioned in the upper layers and have acquired connectivity features of the CPN lineage. The reprogramming abilities of neurons at these later post-mitotic stages of development have not been investigated before for any CNS neuron subtype.
We constructed a conditional expression vector where the Fezf2 expression cassette was cloned in the antisense orientation between two pairs of inverted LoxP sites (DF-Fezf2 eGFP ). We electroporated cortical progenitors at E14. 5 Fig. 4a ). Recombination was induced by injections of TAM at either E17.5, P3 or P21 (Fig. 4 and Supplementary Figs S3 and S4) . TAM administration at P3 and P21 resulted in robust recombination and Fezf2 expression (95.24 ± 0.43% and 93.32 ± 1.99%, respectively; Supplementary Fig. S4a,b) . In parallel experiments, to increase nuclear plasticity, expression of Fezf2 was paired with either administration of valproic acid (VPA) a histone deacetylase inhibitor 26 , or with surgical transection of the corpus callosum (callosotomy) as a CPN-specific type of injury (Fig. 4a ). Pups were killed at P14, P28 and P42.
We found that CPNs that began to express Fezf2 at P3 were still able to reprogram their molecular identity and expressed several CFuPN genes. Similar results were obtained when Fezf2 was induced at E17.5 ( Supplementary Fig. S3 and data not shown). At P28, 25 days after initial Fezf2 expression, these neurons expressed ER81 (22.72 ± 3% versus 0.29% ± 0.29% in DF-Ctl eGFP ); CRYM (8.94 ± 3.46% versus 0% in DF-Ctl eGFP ); Opsin3 and Crim1, two late markers of subcerebral neurons 14 ; and were notably able to induce transcription of the endogenous Fezf2 gene (Fig. 4b,c) . In addition, CPNs expressing DF-Fezf2 eGFP downregulated expression of CUX1 (47.78 ± 1.85% versus 94.47 ± 1.81% in DF-Ctl eGFP ; Fig. 4b,c) . Double marker analysis further showed that 33.56% of the CRYM-positive neurons co-expressed ER81 and 76.51% downregulated CUX1 (Fig. 4d and data not shown). By P28 we could not detect expression of the CFuPN markers CTIP2, TLE4 and ZFPM2 proteins, which at P7 are present in CPNs reprogrammed early post-mitotically (Fig. 1) . These markers might only be expressed by reprogrammed neurons soon after initial expression of Fezf2, or P3 neurons might differ from early post-mitotic neurons at P28. The efficiency of reprogramming remained unaltered by VPA treatment (Fig. 4c) . However, callosotomy increased the percentage of Fezf2-expressing CPNs that was positive for CRYM and negative for CUX1 (Fig. 4c) .
These findings indicate that postnatal CPNs, despite having been post-mitotic for several days still retain the ability to reprogram key aspects of their molecular identity in vivo. Although a significant proportion of CPNs targeted at P3 could reprogram, the efficiency was lower when compared with early post-mitotic neurons, suggesting that a progressive restriction of fate occurs with time during the post-mitotic life of the neuron. To test this possibility, we induced Fezf2 expression in upper-layer CPNs at P21. By P42, we found that virtually all targeted CPNs expressed exogenous Fezf2 (82.52 ± 14.77%). However, neither upregulation of CRYM and ER81 nor downregulation of CUX1 was detected ( Supplementary Fig. S4a-d and data not shown) . The data indicate that CPNs gradually lose their ability to reprogram their molecular identity and suggest the existence of a critical period of nuclear plasticity for post-mitotic neurons.
Neuronal identity is defined as the combination of molecular, morphological and connectivity features. Layer-II/III CPNs and CFuPNs have distinct patterns of axonal connectivity. CPN axons extend across the corpus callosum, with subpopulations maintaining collaterals to the ipsi-and contralateral striatum and to the frontal cortex 12, 27, 28 . CFuPNs, in contrast, project axons below the cortex, through the internal capsule to targets in the thalamus, pons and spinal cord 12 . To determine whether CPNs can reprogram their axonal projections from callosal to corticofugal targets, we first examined the axonal connectivity of pups that had received either Cdk5r-Fezf2 eGFP or control DNA through electroporation at E14.5 and were killed at E18.5, P7, P14, or P28 (Fig. 5) . As expected, in Cdk5r-Ctl eGFP control animals, GFP-positive axon bundles were present crossing the corpus callosum and no axons entered the internal capsule (Fig. 5b, left and upper panels) . In contrast, in Cdk5r-Fezf2 eGFP mice, a reduction in GFP callosal axons was observed at E18.5 (Fig. 5b, right  panels) , and at P7, P14 and P28 distinct axon bundles had entered the internal capsule (Fig. 5c , lower panels and data not shown). In addition, axons of reprogrammed CPNs, but not control CPNs, were able to extend caudally to targets in the thalamus and the cerebral peduncle, and some axons reached the spinal cord (Fig. 5c, lower  panels) . Similar results were obtained when Fezf2 was expressed in CPNs using the Doublecortin promoter, which also restricts expression to early post-mitotic neurons 19, [29] [30] [31] ( Supplementary Fig. S5 ). In all experiments, axons that reached corticofugal targets were maintained at P28 (data not shown).
To determine whether axonal projections could be reprogrammed at a later stage, we followed GFP-positive axons from post-mitotic 
DF-Fezf2
eGFP but not in DF-Ctl eGFP controls (Fig. 5d and data not shown). Together, the data indicate that CPNs retain the ability to reprogram their axonal projections in response to a change of identity imposed post-mitotically. The complexity of axon guidance decisions probably required to achieve such new long-distance connectivity provides further support for the molecular data indicating that a series of neuron subtype-specific genes, rather than individual molecules, is regulated as a result of reprogramming.
Recent work has demonstrated that differentiated cell types can be lineage reprogrammed to acquire a new identity following expression of transcription factors of alternative cell fates [4] [5] [6] [9] [10] [11] 32 . In the CNS, neurogenic transcription factors can reprogram cultured postnatal astrocytes into neural progenitors and neurons [33] [34] [35] . Pericytes isolated from the human cerebral cortex have also recently been shown to reprogram into neurons 36 . However, to what extent neurons have the potential to reprogram their identity is largely unknown. Here, we provide the first demonstration that in the neocortex a conversion between two subtypes of neuron can occur during a temporal window of embryonic and early postnatal development.
The data indicate that critical features of neuronal subtype-specific identity, including the acquisition of a new molecular identity and the ability to extend axons to a new target, can still be changed post-mitotically, even several days after initial fate-specification. These changes occurred despite the ectopic location of the CFuPN-like neurons and through the use of a single transcription factor, suggesting that a higher reprogramming efficiency might be obtained in more instructive environments or by combining Fezf2 with other fatemodifying signals. Importantly, the number of CPNs able to reprogram is highest during the earliest stages of post-mitotic development and, whereas this capacity persists at P3, it is eliminated by P21. This suggests that mechanisms are in place post-mitotically to progressively restrict neuronal fate potential as neurons age. The work indicates that post-mitotic neurons can undergo lineage reprogramming in vivo and paves the way for mechanistic studies aimed at enhancing the process of neuronal conversion by extending the period of neuronal reprogramming to the mature brain.
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